de Gasparo M. , Catt KJ, Inagami T., Wright JW, Unger Th. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev2000;52(3):415-72.
2.
Höhle S., Blume A., Lebrun C., Culman J., Unger T.Angiotensin receptors in the brain. Pharmacol Toxicol1995;77(5):306-15.
3.
McKinley MJ, McAllen RM, Mendelsohn FAO, Allen AM, Chai SY, Oldfield BJCircumventricular organs: Neuroendocrine interfaces between the brain and hemal millieu. Front Neuroendocrinol1990 ;11:91-127.
Fitzsimons JTAngiotensin, thirst, and sodium appetite. Physiol Rev1998;78:583-686.
6.
Davisson RL, Oliviero MI, Coffman TM, Sigmund CDDivergent functions of angiotensin II receptor isoforms in the brain . J Clin Invest2000;106:103-6.
7.
Veltmar A., Culman J., Qadri F., Rascher W., Unger T.Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release. J Pharmacol Exp Ther1992;263(3):1253-60.
8.
Culman J., Hohle S., Qadri F., Edling O., Blume A., Lebrun C., Unger Th. Angiotensin as neuromodulator/neurotransmitter in central control of body fluid and electrolyte homeostasis. Clin Exp Hypertens1995;17(1-2):281-93.
9.
Lenkei Z., Corvol P., Llorens-Cortes C.Comparative expression of vasopressin and angiotensin type-1 receptor mRNA in rat hypothalamic nuclei: a double in situ hybridization study. Mol Brain Res1995;34:135-42.
10.
Saavedra JMBrain and pituitary angiotensin. Endocr Rev1992;13(2):329-80.
11.
Phillips MIAntisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension1997;29:177-87.
12.
Nakamura S. , Moriguchi A., Morishita R. et al. Activation of brain angiotensin system by in vivo human angiotensin-converting enzyme gene transfer in rats. Hypertension1999;34:302-8.
13.
Paton JRF , Kasparov S.Sensory channel specific modulation in the nucleus of the solitary tract. J Autonom Nerv Syst2000;80:117-29.
14.
Unger T.h. The angiotensin type 2 receptor: variations on an enigmatic theme . J Hypertens1999;17:1775-86.
15.
Lucius R., Gallinat S., Busche S., Rosenstiel P., Unger T.h. Beyond blood pressure: new roles for angiotensin II. Cell Mol Life Sci1999;56:1008-19.
16.
Seltzer AM, Zorad S., Saavedra JMStimulation of angiotensin II AT1 receptors in rat median eminence increases phosphoinositide hydrolysis. Brain Res1995 ;705(1-2):24-30.
17.
Yang H., Lu D.,Yu K., Raizada MKRegulation of neuromodulatory actions of angiotensin II in the brain neurons by the Ras-dependent mitogen-activated protein kinase pathway. J Neurosci1996;16(13):4047-58.
18.
Lu D.,Yang H., Raizada MKAngiotensin II regulation of neuromodulation: Downstream signaling mechanism from activation of mitogen-activated protein kinase. J Cell Biol1996; 135:1609-17.
19.
Yang H., Lu D.,Vinson GP, Raizada MKInvolvement of MAP kinase in Angiotensin II-induced phosphorylation and intracelllar targeting of neuronal AT1 receptors. J Neurosci1997; 17:1660-9.
20.
Huang XC, Richards EM, Sumners C.Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors.JBiol Chem1996;271(26):15635-41.
21.
Yu K., Lu D., Rowland NE, Raizada MK.Angiotensin II regulation of tyrosine hydroxylase gene expression in the neuronal cultures of normotensive and spontaneously hypertensive rats . Endocrinology1996;137(8):3566-76.
22.
Yang H., Raizada MKMAP kinase-independent signaling in angiotensin II regulation of neuromodulation in SHR neurons. Hypertension1998;32:473-81.
23.
Zhu M., Neubig RR, Wade SM, Posner P., Gelband CH, Sumners C.Modulation of K+ and Ca2+ currents in cultured neurons by an angiotensin II type 1a receptor peptide. Am J Physiol1997 ;273:C1040-C1048.
24.
Zhu M., Gelband CH, Posner P., Sumners C.Angiotensin II type 1 receptor-mediated inhibition of voltage-dependent K+ current in cultured neurons: role of calcium/calmodulin-dependent protein kinase. FASEB J1998;12:A54.
25.
Yang CR, Phillips MI, Renaud LPAngiotensin II receptor activation depolarizes rat supraoptic neurons in vitro . Am J Physiol1992;321:R1333-R1338.
26.
Huang XC, Deng T., Sumners C. Angiotensin II stimulates activation of Fos-regulating kinase and c-Jun NH2-terminal kinase in neuronal cultures from rat brain. Endocrinology1998;139(1):245-51.
27.
Yang CR, Raizada MKRole of phosphatidylinositol 3-kinase in angiotensin II regulation of norepinephrine neuromodulation in brain neurons of the spontaneously hypertensive rat. J Neurosci1999;19:2413-23.
28.
Herbert J., Forsling ML, Howes SR, Stacey PM, Shiers HMRegional expression of c-fos antigen in the basal forebrain following intraventricular infusion of angiotensin and its modulation by drinking either water or saline . Neuroscience1992;51:867-82.
29.
Blume A., Herdegen T., Unger T.h. Angiotensin peptides and inducible transcription factors. J Mol Med1999;77:339-57.
30.
Rowland NE, Li BH, Fregly MJ, Smith GCFos induced in brain of spontaneously hypertensive rats by angiotensin II and colocalization with AT1 receptors. Brain Res1995;675:127-34.
31.
Blume A., Lebrun CJ, Herdegen T. et al. Increased brain transcription factor expression in genetic hypertension . Hypertension1997; 29:592-8.
32.
Nouet I., Nahmias I.Signal transduction from the angiotensin II AT2 receptor. Trends Endocrinol Metab2000; 11:1-6.
33.
Stroth U., Blume A., Mielke K., Unger T.h. Angiotensin AT2 receptor stimulates ERK1 and ERK2 in quiescent but inhibits ERK in NGF-stimulated PC12W cells. Brain Res Mol Brain Res2000;78:175-80.
34.
Dimmeler S. , Rippmann V., Weiland U., Haendeler J., Zeiher AMAngiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res1997;81:970-6.
35.
Gallinat S. , Busche S., Schütze S., Krönke M., Unger T.AT2 receptor stimulation induces generation of ceramides in PC 12W cells. FEBS Lett1999 ;433: 75-9.
36.
Lehtonen JY , Horiuchi M., Daviet L., Akishita M., Dzau V.Activation of de-novo biosynthesis of sphingolipids mediates angiotensin AT2 receptor-induced apoptosis . J Biol Chem1999;274:16901-6.
37.
Miura S., Karnik SSLigand-independent signals from angiotensin II type 2 receptor induce apoptosis . EMBO J2000; 19:4026-35.
38.
Tsutsumi K. , Saavedra JMCharacterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain. Am J Physiol1991;261:667-70.
39.
Grady EF, Sechi LA, Griffin CA, Schambelan M., Kalinyak JEExpression of AT2 receptors in the developing rat fetus. J Clin Invest1991;88(3):921-33.
40.
UngerTh , Chung O., Csikos T. et al. Angiotensin receptors. J Hypertens1996;14(5)(Suppl):S95-S103.
41.
Sayeski PP, Ali MS, Semeniuk DJ, Doan TN, Bernstein KEAngiotensin II signal transduction pathways. Regul Pept1998;78:19-29.
42.
Meffert S., Stoll M., Steckelings UM, Bottari SP, Unger Th.The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol Cell Endocrinol1996;122(1):59-67.
43.
Laflamme L. , Gasparo M., Gallo JM, Payet MD, Gallo-Payet N.Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors . J Biol Chem1996;271(37):22729-35.
44.
Mesner PW, Epting CL, Hegarty JL, Green SHA timetable of events during programmed cell death induced by trophic factor withdrawal from neuronal PC12 cells. J Neurosci1995; 15:7357-66.
45.
Stroth U., Meffert S., Gallinat S., Unger Th.Angiotensin II and NGF differentially influence microtubule proteins in PC12W cells: role of the AT2 receptor. Mol Brain Res1998;53(1-2):187-95.
46.
Côté F. , Do TH, Laflamme L., Gallo J.- M. Gallo- Payet N.Activation of the AT2 receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum. JBiol Chem1999;274:31686-92.
47.
HerdegenT,Skene P., Bähr M.The c-Jun transcription factor - bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci1997;20:227-31.
Yamada T., Horiuchi M., Dzau VJAngiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA1996;93(1):156-60.
50.
Horiuchi M. , Yamada T., Hayashida W., Kambe T., Yamada T., Dzau VJAngiotensin type2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem1997;272:19022-6.
51.
Horiuchi M. , Akishita M., Dzau VJMolecular and cellular mechanism of angiotensin II-mediated apoptosis. Endocr Res1998;24:307-14.
52.
Gallinat S. , Csikos T., Meffert S., Herdegen T., Stoll M., Unger Th.The angiotensin AT2 receptor down-regulates neurofilament M in PC12W cells. Neurosci Lett1997;227(1):29-32.
53.
Hofmann K., Dixit VMCeramide in apoptosis - does it really matter?TIBS1998;23:374-7.
54.
Lucius R., Gallinat S., Rosenstiel P., Herdegen T., Sievers J., Unger T.h. The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med1998;188:661-70.
55.
Gallinat S. ,Yu M., Dorst A., Unger T., Herdegen T.Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves. Mol Brain Res1998;57(1):111-22.
Dirnagl U., Iadecola C., Moskowitz MAPathobiology of ischaemic stroke: an integrated view. TINS1999;22:391-7.
58.
von Lutterotti N., Camargo MJ, Campbell WG Jr, Mueller FB, Timmermans PB, Sealey JE, Laragh JHAngiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats. J Hypertens1992;10:949-57.
59.
Stier CT Jr, Adler LA, Levien S., Chandler PNStroke prevention by losartan in stroke-prone spontaneously hypertensive rats. J Hypertens1993;11(3)(Suppl):S37-42.
60.
Werner C., Hoffman WE, Kochs E., Rabito SF, Miletich DJCaptopril improves neurologic outcome from incomplete cerebral ischemia in rats. Stroke1991;22:910-4.
61.
Sadoshima S. , Fujii K., Ooboshi H., Ibayashi S., Fujishima M.Angiotensin converting enzyme inhibitors attenuate ischemic brain metabolism in hypertensive rats. Stroke1993;24:1561-7.
62.
Paulson OB, Waldemar G., Andersen AR et al. Role of angiotensin in autoregulation of cerebral blood flow . Circulation1988;77(Suppl I):I-55-58.
63.
Inada Y., Wada T., Ojima M. et al. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens1997;19:1079-99.
64.
Nishimura Y.,Takeshi I., Saavedra JMAngiotensin AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke2000 ;31:2478-86.
65.
Dai WJ, Funk A., Herdegen T., Unger T., Culman J.Blockade of central angiotensin AT1 receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke1999; 30:2391-9.
66.
Makino I., Shibata K., Ohgami Y., Fujiwara M., Furukawa T.Transient upregulation of the AT2 receptor mRNA level after global ischemia in the rat. Neuropeptides1996;30:596-601.
67.
Polidori C. , Ciccocioppo R., Pompei P., Cirillo R., Massi M.Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain in rats. Eur J Pharmacol1996;307:259-67.
68.
Culman J., von Heyer C., Piepenburg B., Rascher W., Unger T.Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats. Eur J Pharmacol1999;367:255-65.
69.
Nishimura Y. , Takeshi I., Hoe K.-L, Saavedra J.M.Chronic peripheral administration of the angiotensin AT1 receptor antagonist Candesartan blocks brain AT1 receptors . Brain Res2000;871:29-38.
70.
Gohlke P., Weiss S., Jansen A. et al. AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats. J Pharmacol Exp Ther2001 (in print).
